Skip to main content
Top
Published in: Respiratory Research 1/2014

Open Access 01-12-2014 | Research

FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure

Authors: Martha Montaño, Raul H Sansores, Carina Becerril, Jose Cisneros, Georgina González-Avila, Bettina Sommer, Leticia Ochoa, Iliana Herrera, Alejandra Ramírez-Venegas, Carlos Ramos

Published in: Respiratory Research | Issue 1/2014

Login to get access

Abstract

Background

Matrix metalloproteinases (MMPs) and C-reactive protein (CRP) are involved in chronic obstructive pulmonary disease (COPD) pathogenesis. The aim of the present work was to determine plasma concentrations of MMPs and CRP in COPD associated to biomass combustion exposure (BE) and tobacco smoking (TS).

Methods

Pulmonary function tests, plasma levels of MMP-1, MMP-7, MMP-9, MMP-9/TIMP-1 and CRP were measured in COPD associated to BE (n = 40) and TS (n =40) patients, and healthy non-smoking (NS) healthy women (controls, n = 40).

Results

Plasma levels of MMP-1, MMP-7, MMP-9, and MMP-9/TIMP-1 and CRP were higher in BE and TS than in the NS healthy women (p <0.01). An inverse correlation between MMP-1, MMP-7, MMP-9, MMP-9/TIMP-1 and CRP plasma concentrations and FEV1 was observed.

Conclusions

Increase of MMPs and CRP plasma concentrations in BE suggests a systemic inflammatory phenomenon similar to that observed in COPD associated to tobacco smoking, which may also play a role in COPD pathogenesis.
Appendix
Available only for authorised users
Literature
3.
go back to reference Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, Ran P: Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010, 138: 20-31.PubMedCrossRef Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, Ran P: Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010, 138: 20-31.PubMedCrossRef
4.
go back to reference Pérez-Padilla R, Regalado J, Vedal S, Paré P, Chapela R, Sansores R, Selman M: Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med. 1996, 54: 701-706.CrossRef Pérez-Padilla R, Regalado J, Vedal S, Paré P, Chapela R, Sansores R, Selman M: Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med. 1996, 54: 701-706.CrossRef
5.
go back to reference Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, Regalado J, Velázquez A, Sánchez C, Mayar ME: Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med. 2006, 173: 393-397.PubMedCrossRef Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, Regalado J, Velázquez A, Sánchez C, Mayar ME: Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med. 2006, 173: 393-397.PubMedCrossRef
6.
go back to reference Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR: Wood smoke health effects: a review. Inhal Toxicol. 2007, 19: 67-106.PubMedCrossRef Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR: Wood smoke health effects: a review. Inhal Toxicol. 2007, 19: 67-106.PubMedCrossRef
7.
go back to reference Rylance J, Gordon SB, Naeher LP, Patel A, Balmes JR, Adetona O, Rogalsky DK, Martin WJ: Household air pollution: a call for studies into biomarkers of exposure and predictors of respiratory disease. Am J Physiol Lung Cell Mol Physiol. 2013, 304: L571-L578.PubMedPubMedCentralCrossRef Rylance J, Gordon SB, Naeher LP, Patel A, Balmes JR, Adetona O, Rogalsky DK, Martin WJ: Household air pollution: a call for studies into biomarkers of exposure and predictors of respiratory disease. Am J Physiol Lung Cell Mol Physiol. 2013, 304: L571-L578.PubMedPubMedCentralCrossRef
8.
go back to reference Ólafsdóttir IS, Janson C, Lind L, Hulthe J, Gunnbjörnsdótti M, Sundströ J: Serum levels of matrix metalloproteinase-9, tissue inhibitors of metalloproteinase-1 and their ratio are associated with impaired lung function in the elderly: a population-based study. Respirology. 2010, 15: 530-535.PubMedCrossRef Ólafsdóttir IS, Janson C, Lind L, Hulthe J, Gunnbjörnsdótti M, Sundströ J: Serum levels of matrix metalloproteinase-9, tissue inhibitors of metalloproteinase-1 and their ratio are associated with impaired lung function in the elderly: a population-based study. Respirology. 2010, 15: 530-535.PubMedCrossRef
9.
go back to reference Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA: Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol. 2005, 5: 257-263.PubMedCrossRef Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA: Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol. 2005, 5: 257-263.PubMedCrossRef
10.
go back to reference Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, Neukirch F, Zureik M: Change in C-reactive levels and FEV1 decline: a longitudinal population-based study. Respir Med. 2006, 100: 2112-2120.PubMedCrossRef Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, Neukirch F, Zureik M: Change in C-reactive levels and FEV1 decline: a longitudinal population-based study. Respir Med. 2006, 100: 2112-2120.PubMedCrossRef
11.
go back to reference Dahl M, Vestbo J, Zacho J, Lange P, Tybjærg-Hansen A, Nordestgaard BG: C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax. 2011, 66: 197-204.PubMedCrossRef Dahl M, Vestbo J, Zacho J, Lange P, Tybjærg-Hansen A, Nordestgaard BG: C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax. 2011, 66: 197-204.PubMedCrossRef
12.
go back to reference Menezes AM, Victora CG, Perez-Padilla R, PLATINO Team: The Platino project. Methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004, 4: 15-PubMedPubMedCentralCrossRef Menezes AM, Victora CG, Perez-Padilla R, PLATINO Team: The Platino project. Methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004, 4: 15-PubMedPubMedCentralCrossRef
13.
go back to reference Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555.PubMedCrossRef Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555.PubMedCrossRef
14.
go back to reference Celli BR, MacNee W: ATS/ERS task force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23: 932-946.PubMedCrossRef Celli BR, MacNee W: ATS/ERS task force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23: 932-946.PubMedCrossRef
15.
go back to reference Pérez-Padilla R, Regalado J, Vázquez-García JC: Reproducibilidad espirométrica y adecuación a valores de referencia internacionales en trabajadores mexicanos demandando incapacidad. Salud Publ Mex. 2001, 43: 113-121. Pérez-Padilla R, Regalado J, Vázquez-García JC: Reproducibilidad espirométrica y adecuación a valores de referencia internacionales en trabajadores mexicanos demandando incapacidad. Salud Publ Mex. 2001, 43: 113-121.
16.
go back to reference Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159: 179-187.PubMedCrossRef Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159: 179-187.PubMedCrossRef
17.
go back to reference Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Boeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem. 1985, 150: 76-85.PubMedCrossRef Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Boeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem. 1985, 150: 76-85.PubMedCrossRef
18.
go back to reference Morandi MT, Ward TJ: The risk assessment workgroup. Biomass risk assessment: defining the questions. Inhal Toxicol. 2010, 22: 94-98.PubMedCrossRef Morandi MT, Ward TJ: The risk assessment workgroup. Biomass risk assessment: defining the questions. Inhal Toxicol. 2010, 22: 94-98.PubMedCrossRef
19.
go back to reference Chung KF, Adcock IM: Multifaceted mechanisms in COPD. Inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008, 31: 1334-1356.PubMedCrossRef Chung KF, Adcock IM: Multifaceted mechanisms in COPD. Inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008, 31: 1334-1356.PubMedCrossRef
20.
go back to reference Higashimoto Y, Yamagata Y, Iwata T, Okada M, Ishiguchi T, Sato H, Masuda M, Itoh H: Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. Eur Respir J. 2005, 25: 885-890.PubMedCrossRef Higashimoto Y, Yamagata Y, Iwata T, Okada M, Ishiguchi T, Sato H, Masuda M, Itoh H: Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. Eur Respir J. 2005, 25: 885-890.PubMedCrossRef
21.
go back to reference Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M: Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease. Respirology. 2012, 17: 1006-1012.PubMedCrossRef Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M: Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease. Respirology. 2012, 17: 1006-1012.PubMedCrossRef
22.
go back to reference Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B: Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 2007, 62: 595-601.PubMedPubMedCentralCrossRef Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B: Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 2007, 62: 595-601.PubMedPubMedCentralCrossRef
23.
go back to reference Skjot-Arkil H, Clausen RE, Nguyen QHT, Wang Y, Zheng Q, Martinez FJ, Hogaboam CM, Han M, Kickstein L, Larsen MR, Nawrocki A, Leeming DJ, Karsdal MA: Measurement of MMP-9 and MMP-12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMX Pulm Med. 2012, 12: 34-CrossRef Skjot-Arkil H, Clausen RE, Nguyen QHT, Wang Y, Zheng Q, Martinez FJ, Hogaboam CM, Han M, Kickstein L, Larsen MR, Nawrocki A, Leeming DJ, Karsdal MA: Measurement of MMP-9 and MMP-12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMX Pulm Med. 2012, 12: 34-CrossRef
24.
go back to reference Simpson JL, McDonald VM, Baines KJ, Oreo KM, Wang F, Hansbro PM, Gibson PG: Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD. Mediat Inflamm. 2013, 2013: 462934-CrossRef Simpson JL, McDonald VM, Baines KJ, Oreo KM, Wang F, Hansbro PM, Gibson PG: Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD. Mediat Inflamm. 2013, 2013: 462934-CrossRef
25.
go back to reference Noguera A, Gomez C, Faner R, Cosio B, Gonzalez-Periz A, Claria J, Carvajal A, Agusti A: An investigation of the resolution of inflammation (catabasis) in COPD. Respir Res. 2012, 13: 1-9.CrossRef Noguera A, Gomez C, Faner R, Cosio B, Gonzalez-Periz A, Claria J, Carvajal A, Agusti A: An investigation of the resolution of inflammation (catabasis) in COPD. Respir Res. 2012, 13: 1-9.CrossRef
26.
go back to reference Ilumets H, Rytila P, Demedts I, Brusselle GG, Sovijarvi A, Myllarniemi M, Sorsa T, Kinnnula VL: Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD. Int J Chron Obstruct Pulmon Dis. 2007, 2: 369-379.PubMedPubMedCentral Ilumets H, Rytila P, Demedts I, Brusselle GG, Sovijarvi A, Myllarniemi M, Sorsa T, Kinnnula VL: Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD. Int J Chron Obstruct Pulmon Dis. 2007, 2: 369-379.PubMedPubMedCentral
27.
go back to reference Ilumets H, Mazur W, Tojamo T, Louhelainen N, Nieminen P, Kobayashi H, Ishikawa N, Kinnula VL: Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med. 2011, 11: 19-28.PubMedPubMedCentralCrossRef Ilumets H, Mazur W, Tojamo T, Louhelainen N, Nieminen P, Kobayashi H, Ishikawa N, Kinnula VL: Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med. 2011, 11: 19-28.PubMedPubMedCentralCrossRef
28.
go back to reference Kang MJ, Oh YM, Lee JC, Kim DG, Park MJ, Lee MG, Hyun IG, Han SK, Shim YS, Jung KS: Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sci. 2003, 18: 821-827.PubMedPubMedCentralCrossRef Kang MJ, Oh YM, Lee JC, Kim DG, Park MJ, Lee MG, Hyun IG, Han SK, Shim YS, Jung KS: Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sci. 2003, 18: 821-827.PubMedPubMedCentralCrossRef
29.
go back to reference Brajer B, Batura-Gabryel H, Mowicka A, Kuznar-Kaminska B, Szczepanik A: Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol. 2008, 59 (Suppl 6): 145-152.PubMed Brajer B, Batura-Gabryel H, Mowicka A, Kuznar-Kaminska B, Szczepanik A: Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol. 2008, 59 (Suppl 6): 145-152.PubMed
30.
go back to reference D’Armiento JM, Goldklang MP, Hardigan AA, Geraghty P, Roth MD, Connett JE, Wise RA, Sciurba FC, Scharf SM, Thankachen J, Islam M, Ghio AJ, Foronjy RF: Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema. PLoS One. 2013, 8: e56352-PubMedPubMedCentralCrossRef D’Armiento JM, Goldklang MP, Hardigan AA, Geraghty P, Roth MD, Connett JE, Wise RA, Sciurba FC, Scharf SM, Thankachen J, Islam M, Ghio AJ, Foronjy RF: Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema. PLoS One. 2013, 8: e56352-PubMedPubMedCentralCrossRef
31.
go back to reference Kwiatkowska S, Noweta K, Zieba M, Nowak D, Bialasiewicz P: Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase- in patients with COPD exacerbations: prospective study. Respiration. 2012, 804: 231-241.CrossRef Kwiatkowska S, Noweta K, Zieba M, Nowak D, Bialasiewicz P: Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase- in patients with COPD exacerbations: prospective study. Respiration. 2012, 804: 231-241.CrossRef
32.
go back to reference De Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR, Casanova C: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006, 27: 902-907.PubMed De Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR, Casanova C: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006, 27: 902-907.PubMed
33.
go back to reference Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y: Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009, 103: 1231-1238.PubMedCrossRef Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y: Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009, 103: 1231-1238.PubMedCrossRef
34.
go back to reference Funda A, Funda A, Nermin Ç, Kurtuluş A, Ruhsar O, Sema C, Bünyamin Y, Kadir Okhan A: C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013, 5: 414-421. Funda A, Funda A, Nermin Ç, Kurtuluş A, Ruhsar O, Sema C, Bünyamin Y, Kadir Okhan A: C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013, 5: 414-421.
Metadata
Title
FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure
Authors
Martha Montaño
Raul H Sansores
Carina Becerril
Jose Cisneros
Georgina González-Avila
Bettina Sommer
Leticia Ochoa
Iliana Herrera
Alejandra Ramírez-Venegas
Carlos Ramos
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2014
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-15-74

Other articles of this Issue 1/2014

Respiratory Research 1/2014 Go to the issue